Use of IP chemotherapy in ovarian cancer: the critical questions

Oncology (Williston Park). 2011 Feb;25(2):170, 173-4.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage
  • Disease-Free Survival
  • Female
  • Humans
  • Infusions, Parenteral
  • Neoplasms, Glandular and Epithelial / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Taxoids / administration & dosage

Substances

  • Taxoids
  • Cisplatin